Your browser doesn't support javascript.
loading
High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.
Jha, Abhishek; Taïeb, David; Carrasquillo, Jorge A; Pryma, Daniel A; Patel, Mayank; Millo, Corina; de Herder, Wouter W; Del Rivero, Jaydira; Crona, Joakim; Shulkin, Barry L; Virgolini, Irene; Chen, Alice P; Mittal, Bhagwant R; Basu, Sandip; Dillon, Joseph S; Hope, Thomas A; Mari Aparici, Carina; Iagaru, Andrei H; Hicks, Rodney J; Avram, Anca M; Strosberg, Jonathan R; Civelek, Ali Cahid; Lin, Frank I; Pandit-Taskar, Neeta; Pacak, Karel.
Afiliação
  • Jha A; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland.
  • Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.
  • Carrasquillo JA; Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Pryma DA; Department of Radiology, Weill Cornell Medical College, New York, New York.
  • Patel M; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Millo C; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland.
  • de Herder WW; Department of Positron Emission Tomography, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Del Rivero J; Section of Endocrinology, Department of Internal Medicine, ENETS Centre of Excellence, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.
  • Crona J; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Shulkin BL; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Virgolini I; Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Chen AP; Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.
  • Mittal BR; Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.
  • Basu S; Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Dillon JS; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Hope TA; Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
  • Mari Aparici C; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.
  • Iagaru AH; Divisions of Nuclear Medicine and Molecular Imaging, Stanford University School of Medicine, Stanford, California.
  • Hicks RJ; Divisions of Nuclear Medicine and Molecular Imaging, Stanford University School of Medicine, Stanford, California.
  • Avram AM; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Strosberg JR; Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, Michigan.
  • Civelek AC; Division of Neuroendocrine Tumor/Department of Gastrointestinal Medicine, Moffitt Cancer Center, Tampa, Florida.
  • Lin FI; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Radiological Sciences, Johns Hopkins Medicine, Baltimore, Maryland.
  • Pandit-Taskar N; Molecular Imaging Program, NCI, NIH, Bethesda, Maryland.
  • Pacak K; Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York. karel@mail.nih.gov pandit-n@mskcc.org.
Clin Cancer Res ; 27(11): 2989-2995, 2021 06 01.
Article em En | MEDLINE | ID: mdl-33685867
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Paraganglioma / Feocromocitoma / Radioisótopos / Radioterapia / Octreotida / Neoplasias das Glândulas Suprarrenais / Compostos Radiofarmacêuticos / 3-Iodobenzilguanidina / Radioisótopos do Iodo Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Paraganglioma / Feocromocitoma / Radioisótopos / Radioterapia / Octreotida / Neoplasias das Glândulas Suprarrenais / Compostos Radiofarmacêuticos / 3-Iodobenzilguanidina / Radioisótopos do Iodo Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article